Pluripotent stem cells
|
Embryonic stem cells (ESCs) Induced pluripotent stem cells (iPSCs)
|
Surplus human IVF blastocysts (ESCs) Reprogrammed somatic cells (iPSCs)
|
Can produce any cell in the body (ESCs, iPSCs)
|
Unlimited self-renewal capacity in vitro (ESCs, iPSCs)
|
Difficult to generate pure populations of mature cells with current culture conditions (ESCs, iPSCs)
|
Perceived ethical issues with some community groups (ESCs)
|
Can be used for autologous (iPSC) or allogenic (ESC, iPSC) treatment
|
Tissue-specific stem cells |
Hematopoietic stem cells (HSCs) Skin stem cells (SSCs) Mesenchymal stem cells (MSCs) |
Bone marrow (HSCs, MSCs) Peripheral blood (HSCs)
|
Normally produce only cells from the particular tissue in which they are found
|
Skin (SSCs)
|
Typically have limited self-renewal and expansion capacity in vitro with current culture conditions
|
Fat (MSCs)
|
Cartilage (MSCs) |
Difficult to generate pure populations of mature cells with current culture conditions
|
Can be used for autologous or allogenic treatment |